中国急性骨筋膜室综合征早期诊断与治疗指南(2020版)

2020-08-30 中华医学会骨科学分会 中华创伤骨科杂志.2020,22(8):645-654.

急性骨筋膜室综合征(ACS)是创伤骨科的严重并发症之一。随着现代社会的快速发展,高能量损伤、多发伤及多发性骨折日趋增多,ACS的发生率呈上升趋势。然而,目前尚有部分医护人员对此综合征的发病机制、早期诊

中文标题:

中国急性骨筋膜室综合征早期诊断与治疗指南(2020版)

发布日期:

2020-08-30

简要介绍:

急性骨筋膜室综合征(ACS)是创伤骨科的严重并发症之一。随着现代社会的快速发展,高能量损伤、多发伤及多发性骨折日趋增多,ACS的发生率呈上升趋势。然而,目前尚有部分医护人员对此综合征的发病机制、早期诊断及处理原则等认识不清,在发病早期未能及时诊断及有效治疗,耽误宝贵的救治时机,导致患者出现伤肢永久性功能障碍或截肢,甚至危及生命。目前对于ACS的诊断和治疗还存在争议,国内仍缺乏该领域相关的诊疗共识。为规范ACS的诊断和治疗,帮助临床医生正确处理ACS,专家组根据ACS患者的临床特点,基于现有相关科研和技术的系统回顾研究、临床信息和公认的诊断和治疗方法,结合我国患者的特点,围绕ACS早期诊断和正确治疗编写本指南,以期进一步指导、规范临床诊疗行为。

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1054344, encodeId=a15e105434491, content=好指南,有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca385602682, createdName=ms4000002037659389, createdTime=Fri Sep 24 07:12:04 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912379, encodeId=f9489123e96e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/f6a458852b244fd9924395cd6a875f20/257a6465b8834e45999b8fbca1ed8127.jpg, createdBy=f8f95448998, createdName=辛易, createdTime=Wed Dec 30 23:20:08 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909127, encodeId=cd4390912ee5, content=有理有据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b62930849, createdName=349398250, createdTime=Fri Dec 18 15:03:42 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904699, encodeId=e1789046994d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65e95338964, createdName=ms7000000598030003, createdTime=Thu Dec 03 22:45:41 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901193, encodeId=928390119326, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01085320051, createdName=148a7b64m35暂无昵称, createdTime=Sun Nov 22 15:47:24 CST 2020, time=2020-11-22, status=1, ipAttribution=)]
    2021-09-24 ms4000002037659389

    好指南,有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1054344, encodeId=a15e105434491, content=好指南,有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca385602682, createdName=ms4000002037659389, createdTime=Fri Sep 24 07:12:04 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912379, encodeId=f9489123e96e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/f6a458852b244fd9924395cd6a875f20/257a6465b8834e45999b8fbca1ed8127.jpg, createdBy=f8f95448998, createdName=辛易, createdTime=Wed Dec 30 23:20:08 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909127, encodeId=cd4390912ee5, content=有理有据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b62930849, createdName=349398250, createdTime=Fri Dec 18 15:03:42 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904699, encodeId=e1789046994d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65e95338964, createdName=ms7000000598030003, createdTime=Thu Dec 03 22:45:41 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901193, encodeId=928390119326, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01085320051, createdName=148a7b64m35暂无昵称, createdTime=Sun Nov 22 15:47:24 CST 2020, time=2020-11-22, status=1, ipAttribution=)]
    2020-12-30 辛易

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1054344, encodeId=a15e105434491, content=好指南,有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca385602682, createdName=ms4000002037659389, createdTime=Fri Sep 24 07:12:04 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912379, encodeId=f9489123e96e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/f6a458852b244fd9924395cd6a875f20/257a6465b8834e45999b8fbca1ed8127.jpg, createdBy=f8f95448998, createdName=辛易, createdTime=Wed Dec 30 23:20:08 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909127, encodeId=cd4390912ee5, content=有理有据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b62930849, createdName=349398250, createdTime=Fri Dec 18 15:03:42 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904699, encodeId=e1789046994d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65e95338964, createdName=ms7000000598030003, createdTime=Thu Dec 03 22:45:41 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901193, encodeId=928390119326, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01085320051, createdName=148a7b64m35暂无昵称, createdTime=Sun Nov 22 15:47:24 CST 2020, time=2020-11-22, status=1, ipAttribution=)]
    2020-12-18 349398250

    有理有据

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1054344, encodeId=a15e105434491, content=好指南,有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca385602682, createdName=ms4000002037659389, createdTime=Fri Sep 24 07:12:04 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912379, encodeId=f9489123e96e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/f6a458852b244fd9924395cd6a875f20/257a6465b8834e45999b8fbca1ed8127.jpg, createdBy=f8f95448998, createdName=辛易, createdTime=Wed Dec 30 23:20:08 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909127, encodeId=cd4390912ee5, content=有理有据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b62930849, createdName=349398250, createdTime=Fri Dec 18 15:03:42 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904699, encodeId=e1789046994d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65e95338964, createdName=ms7000000598030003, createdTime=Thu Dec 03 22:45:41 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901193, encodeId=928390119326, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01085320051, createdName=148a7b64m35暂无昵称, createdTime=Sun Nov 22 15:47:24 CST 2020, time=2020-11-22, status=1, ipAttribution=)]
    2020-12-03 ms7000000598030003

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1054344, encodeId=a15e105434491, content=好指南,有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca385602682, createdName=ms4000002037659389, createdTime=Fri Sep 24 07:12:04 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912379, encodeId=f9489123e96e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/f6a458852b244fd9924395cd6a875f20/257a6465b8834e45999b8fbca1ed8127.jpg, createdBy=f8f95448998, createdName=辛易, createdTime=Wed Dec 30 23:20:08 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909127, encodeId=cd4390912ee5, content=有理有据, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b62930849, createdName=349398250, createdTime=Fri Dec 18 15:03:42 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904699, encodeId=e1789046994d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65e95338964, createdName=ms7000000598030003, createdTime=Thu Dec 03 22:45:41 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901193, encodeId=928390119326, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01085320051, createdName=148a7b64m35暂无昵称, createdTime=Sun Nov 22 15:47:24 CST 2020, time=2020-11-22, status=1, ipAttribution=)]
    2020-11-22 148a7b64m35暂无昵称

    好指南

    0

拓展阅读